Treatment of Staphylococcus hominis Infections
Staphylococcus hominis infections should be treated with appropriate antibiotics when they cause invasive disease, are associated with prosthetic material, or occur in immunocompromised patients. 1, 2
When to Treat S. hominis Infections
Treatment decisions for S. hominis should be based on:
Clinical presentation and severity:
Patient factors:
- Immunocompromised status
- Presence of comorbidities
- Extremes of age
Treatment Approach
For Skin and Soft Tissue Infections (SSTIs):
For purulent SSTIs (abscesses):
For purulent cellulitis:
For non-purulent cellulitis:
Antibiotic Options:
Outpatient oral options:
For hospitalized patients with complicated SSTIs:
Special Considerations:
For prosthetic material-associated infections:
- Consider removal of foreign material when possible 2
- Longer duration of therapy may be needed
For invasive infections (bacteremia, endocarditis):
- IV antibiotics based on susceptibility testing
- Consider surgical intervention for source control 1
For pediatric patients:
- Mupirocin 2% topical ointment for minor skin infections (A-III)
- Avoid tetracyclines in children <8 years (A-II)
- For hospitalized children with complicated SSTIs:
Important Considerations
Obtain cultures from abscesses and purulent SSTIs in patients:
- Receiving antibiotic therapy
- With severe local infection or systemic illness
- Who have not responded to initial treatment
- When concerned about a cluster or outbreak 4
Antimicrobial resistance:
Duration of therapy:
Prevention of Recurrent Infections
For patients with recurrent infections:
- Maintain good personal hygiene
- Keep draining wounds covered
- Avoid sharing personal items
- Consider decolonization strategies in selected cases 4